John F. Crowley - Jan 2, 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Executive Chairman, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Jan 2, 2023
Transactions value $
-$527,531
Form type
4
Date filed
1/4/2023, 06:16 PM
Previous filing
Dec 19, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Tax liability -$264K -21.6K -2.73% $12.21 770K Jan 2, 2023 Direct
transaction FOLD Common Stock Tax liability -$264K -22.1K -2.87% $11.93 748K Jan 3, 2023 Direct
transaction FOLD Common Stock Award $0 +233K +31.19% $0.00 981K Jan 3, 2023 Direct F1
holding FOLD Common Stock 64.9K Jan 2, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +414K $0.00 414K Jan 3, 2023 Common Stock 414K $11.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F2 One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

Remarks:

In addition to the reported transactions, Mr. Crowley also has approximately 750,000 options outstanding and exercisable at various strike prices.